Belite Bio announces American Depositary shares offering, no amount given

Belite Bio (BLTE) announced that it has commenced an underwritten public offering of American Depositary shares, or ADSs, each representing one of its ordinary shares. All of the securities in the offering are to be sold by Belite Bio. Belite Bio intends to use the net proceeds of the offering for (i) commercialization preparation, including building our in-house commercialization team, establishing sales network and systems, and preparing for the commercial manufacture of our future products, if approved, (ii) development and expansion of pipelines, and (iii) working capital and other general corporate purposes. Morgan Stanley & Co., Leerink Partners, BofA Securities and Cantor are acting as joint active book-running managers for the offering.